Progyny, Inc. PGNY
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +13.67%
- 1 year
- +56.51%
- Open
- 28.66
- Prev close
- 28.40
- Mkt cap
- 2.24B
- Vol
- 807.73K
- Avg vol
- 1.10M
- EPS
- 0.92
- P/E
- 31.73
- Div yield
- 0.00%
More statistics
- Low
- 28.35
- High
- 29.22
- Forward P/E
- 12.62
- Beta
- 1.02
- Short ratio
- 4.06
- Inst. own
- 108.07%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 26.81
- 200-d avg
- 24.34
- 1y target
- 34.42
5D chart
Signals (86)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 9:30 AM | 2 days ago |
| RSI: Overbought | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 11:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:45 AM | 3 days ago |
| RSI: Overbought | Oct 29, 11:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:10 AM | 3 days ago |
| RSI: Overbought | Oct 29, 11:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 10:10 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:40 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:40 PM | 5 days ago |
| RSI: Oversold | Oct 27, 2:20 PM | 5 days ago |
| RSI: Oversold | Oct 27, 2:00 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:50 PM | 5 days ago |
| RSI: Oversold | Oct 27, 1:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:45 PM | 5 days ago |
| RSI: Oversold | Oct 27, 1:30 PM | 5 days ago |
| RSI: Oversold | Oct 27, 1:05 PM | 5 days ago |
| RSI: Oversold | Oct 27, 12:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:05 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:05 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:55 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:55 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:35 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:25 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:35 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 12:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 10:35 AM | 6 days ago |
News
4 days ago globenewswire.com
New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits
Research presented at ASRM 2026 Scientific Congress & Expo highlights the importance of early engagement and personalized support in helping patients navigate fertility care Research presented at…
6 days ago globenewswire.com
New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced findings from a new clinical outcomes study…
1 week ago globenewswire.com
Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period…
1 week ago defenseworld.net
Progyny (NASDAQ:PGNY) COO Sells $52,612.00 in Stock
Progyny, Inc. (NASDAQ: PGNY - Get Free Report) COO Melissa Cummings sold 1,879 shares of the stock in a transaction dated Wednesday, October 14th. The stock was sold at an average price of $28.00,…
2 weeks ago globenewswire.com
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, announced today that it will present new research evaluating…
3 weeks ago zacks.com
Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?
Progyny (PGNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in…
3 weeks ago zacks.com
PGNY or CRL: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Progyny (PGNY) and Charles River Laboratories (CRL). But which of these two companies is the best option for those looking for…
3 weeks ago globenewswire.com
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
Expecting 1.2 Million New Covered Lives from Commitments to Date and Anticipated Remaining Decisions Reflects How Employers are Increasingly Turning to Solutions with a Proven Track Record of…
1 month ago zacks.com
PGNY vs. CRL: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Progyny (PGNY) or Charles River Laboratories (CRL). But which of these two stocks presents investors with the…
1 month ago seekingalpha.com
Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027
Progyny (PGNY) remains the US market leader in fertility benefits management, demonstrating robust growth, improving margins, and a compelling valuation despite recent volatility. PGNY's Q2 2026…
1 month ago zacks.com
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know
The mean of analysts' price targets for Progyny (PGNY) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among…
-
1 month ago benzinga.com
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $31 to $33.
1 month ago globenewswire.com
Progyny, Inc. to Present at the Wells Fargo Healthcare Conference
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Chief Financial Officer Mark…
2 months ago defenseworld.net
Hsbc Holdings PLC Makes New $760,000 Investment in Progyny, Inc. $PGNY
Hsbc Holdings PLC acquired a new stake in shares of Progyny, Inc. (NASDAQ: PGNY) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
2 months ago defenseworld.net
23,600 Shares in Progyny, Inc. $PGNY Bought by Canada Pension Plan Investment Board
Canada Pension Plan Investment Board acquired a new stake in Progyny, Inc. (NASDAQ: PGNY) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional…
2 months ago defenseworld.net
Progyny, Inc. (NASDAQ:PGNY) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Progyny, Inc. (NASDAQ: PGNY - Get Free Report) have been given an average rating of "Moderate Buy" by the thirteen analysts that are covering the stock, Marketbeat.com reports. Three…
2 months ago defenseworld.net
AWM Investment Company Inc. Purchases Shares of 220,000 Progyny, Inc. $PGNY
AWM Investment Company Inc. bought a new position in shares of Progyny, Inc. (NASDAQ: PGNY) during the second quarter, according to its most recent 13F filing with the Securities and Exchange…
2 months ago zacks.com
Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns
MNDY, MTCH, PGNY and WK make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
-
2 months ago benzinga.com
JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30
JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $27 to $30.
-
2 months ago benzinga.com
Wells Fargo Initiates Coverage On Progyny with Overweight Rating, Announces Price Target of $37
Wells Fargo analyst Stan Berenshteyn initiates coverage on Progyny (NASDAQ:PGNY) with a Overweight rating and announces Price Target of $37.
2 months ago defenseworld.net
Bank of America Corp DE Grows Stake in Progyny, Inc. $PGNY
Bank of America Corp DE boosted its stake in shares of Progyny, Inc. (NASDAQ: PGNY) by 75.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange…
2 months ago marketbeat.com
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
Progyny NASDAQ: PGNY CEO Pete Anevski said the company expects member engagement and utilization to rebound following a more pronounced summer seasonal slowdown, while early renewal and new-client…
-
2 months ago benzinga.com
Truist Securities Maintains Buy on Progyny, Raises Price Target to $36
Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $33 to $36.
2 months ago defenseworld.net
California State Teachers Retirement System Purchases 23,273 Shares of Progyny, Inc. $PGNY
California State Teachers Retirement System lifted its position in shares of Progyny, Inc. (NASDAQ: PGNY) by 30.4% in the undefined quarter, according to its most recent Form 13F filing with the…
-
2 months ago benzinga.com
Barclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30
Barclays analyst Peter Warendorf maintains Progyny (NASDAQ:PGNY) with a Equal-Weight and lowers the price target from $34 to $30.
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report…
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings…
-
2 months ago benzinga.com
Progyny Sees Q3 Adj EPS $0.50-$0.52 vs $0.33 Est; Sees Sales $335.000M-$345.000M vs $350.185M Est
Progyny (NASDAQ:PGNY) is looking for Q3 Adj EPS of $0.50-$0.52 vs $0.33 analyst estimate. sees sales of $335.000 million-$345.000 million vs $350.185 million analyst estimate.
-
2 months ago benzinga.com
Progyny Raises FY2026 Adj EPS Guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 Est; Lowers FY2026 Sales Guidance from $1.365B-$1.405B to $1.360B-$1.385B vs $1.384B Est
Progyny (NASDAQ:PGNY) raises FY2026 Adj EPS guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 analyst estimate. Lowers FY2026 sales outlook from $1.365 billion-$1.405 billion to $1.360 billion-$1.385…
-
2 months ago benzinga.com
Progyny Q2 Adj. EPS $0.55 Beats $0.34 Estimate, Sales $350.511M Beat $348.682M Estimate
Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.34 by 61.76 percent. This is a 14.58 percent increase over earnings of $0.48 per…
3 months ago benzinga.com
This Clorox Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Wall Street analysts change outlook on top stocks. See upgrade, downgrade, and initiation changes on our analyst ratings page. CLX stock has mixed reviews.
-
3 months ago benzinga.com
Barclays Downgrades Progyny to Equal-Weight, Raises Price Target to $34
Barclays analyst Peter Warendorf downgrades Progyny (NASDAQ:PGNY) from Overweight to Equal-Weight and raises the price target from $27 to $34.
-
3 months ago benzinga.com
BTIG Maintains Buy on Progyny, Raises Price Target to $40
BTIG analyst David Larsen maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $30 to $40.
-
3 months ago benzinga.com
Canaccord Genuity Maintains Buy on Progyny, Raises Price Target to $36
Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $30 to $36.
3 months ago benzinga.com
Top 3 Health Care Stocks That May Implode This Month
Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia Health have high RSI values and strong price action.
-
3 months ago benzinga.com
Keybanc Maintains Overweight on Progyny, Raises Price Target to $35
Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $30 to $35.
-
4 months ago benzinga.com
Truist Securities Maintains Buy on Progyny, Raises Price Target to $33
Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $30 to $33.
-
5 months ago benzinga.com
B of A Securities Maintains Buy on Progyny, Raises Price Target to $31
B of A Securities analyst Michael Cherny maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $29 to $31.
5 months ago benzinga.com
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday
Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. See what other analysts think of these stocks.
-
5 months ago benzinga.com
Canaccord Genuity Upgrades Progyny to Buy, Raises Price Target to $30
Canaccord Genuity analyst Richard Close upgrades Progyny (NASDAQ:PGNY) from Hold to Buy and raises the price target from $19 to $30.
-
5 months ago benzinga.com
Barclays Maintains Overweight on Progyny, Raises Price Target to $27
Barclays analyst Glen Santangelo maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $23 to $27.
-
5 months ago benzinga.com
Truist Securities Maintains Buy on Progyny, Raises Price Target to $30
Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $28 to $30.
-
5 months ago benzinga.com
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $31
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $30 to $31.
5 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
5 months ago benzinga.com
Progyny Sees Q2 Adj EPS $0.50-$0.53 vs $0.33 Est; Sees Sales $342.000M-$355.000M vs $347.385M Est
Progyny (NASDAQ:PGNY) is looking for Q2 Adj EPS of $0.50-$0.53 vs $0.33 analyst estimate. sees sales of $342.000 million-$355.000 million vs $347.385 million analyst estimate.
-
5 months ago benzinga.com
Progyny Raises FY2026 Adj EPS Guidance from $1.83-$1.95 to $1.98-$2.09 vs $1.32 Est; Raises FY2026 Sales Guidance from $1.355B-$1.405B to $1.365B-$1.405B vs $1.376B Est
Progyny (NASDAQ:PGNY) raises FY2026 Adj EPS guidance from $1.83-$1.95 to $1.98-$2.09 vs $1.32 analyst estimate. Raises FY2026 sales outlook from $1.355 billion-$1.405 billion to $1.365 billion-$1.405…
8 months ago benzinga.com
Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED)
Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED)
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session